Labeler
Medexus Pharma Inc. NDC Codes
Medexus Pharma Inc. lists 18 finished drug products in the FDA NDC Directory under NDC labeler code 59137.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Rasuvo, Ixinity, Grafapex, Hexatrione 2%
- Active ingredients
- Methotrexate sodium, Treosulfan, Triamcinolone hexacetonide
- NDC labeler codes
- 59137
- Strengths
- Treosulfan 1000 mg/g; Treosulfan 5000 mg/5g; Triamcinolone hexacetonide 40 mg/2mL; Methotrexate sodium 7.5 mg/.15mL; Methotrexate sodium 10 mg/.2mL; Methotrexate sodium 12.5 mg/.25mL; Methotrexate sodium 15 mg/.3mL; Methotrexate sodium 17.5 mg/.35mL; Methotrexate sodium 20 mg/.4mL; Methotrexate sodium 22.5 mg/.45mL; Methotrexate sodium 25 mg/.5mL; Methotrexate sodium 30 mg/.6mL
- Dosage forms
- Injection, Solution, Kit, Injection, Powder, Lyophilized, For solution, Injection, Suspension
- Routes
- Subcutaneous, Intravenous, Intra-articular
- Drug classes (FDA established)
- Folate Analog Metabolic Inhibitor, Corticosteroid
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 25
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Grafapextreosulfan | Treosulfan 1000 mg/g | Injection, Powder, Lyophilized, For solutionIntravenous | 59137-335 | 59137-0335-01 | — |
| Grafapextreosulfan | Treosulfan 5000 mg/5g | Injection, Powder, Lyophilized, For solutionIntravenous | 59137-365 | 59137-0365-01 | — |
| Hexatrione 2%triamcinolone hexacetonide | Triamcinolone hexacetonide 40 mg/2mL | Injection, SuspensionIntra-articular | 59137-570 | 59137-0570-01 | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-282 | 59137-0282-05 | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-283 | 59137-0283-05 | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-284 | 59137-0284-05 | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-287 | — | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-288 | — | — |
| Ixinitycoagulation factor ix (recombinant) | — | Kit | 59137-289 | 59137-0289-05 | — |
| Rasuvomethotrexate | Methotrexate sodium 7.5 mg/.15mL | Injection, SolutionSubcutaneous | 59137-505 | 59137-0505-0159137-0505-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 10 mg/.2mL | Injection, SolutionSubcutaneous | 59137-510 | 59137-0510-0159137-0510-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 12.5 mg/.25mL | Injection, SolutionSubcutaneous | 59137-515 | 59137-0515-0159137-0515-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 15 mg/.3mL | Injection, SolutionSubcutaneous | 59137-520 | 59137-0520-0159137-0520-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 17.5 mg/.35mL | Injection, SolutionSubcutaneous | 59137-525 | 59137-0525-0159137-0525-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 20 mg/.4mL | Injection, SolutionSubcutaneous | 59137-530 | 59137-0530-0159137-0530-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 22.5 mg/.45mL | Injection, SolutionSubcutaneous | 59137-535 | 59137-0535-0159137-0535-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 25 mg/.5mL | Injection, SolutionSubcutaneous | 59137-540 | 59137-0540-0159137-0540-04 | — |
| Rasuvomethotrexate | Methotrexate sodium 30 mg/.6mL | Injection, SolutionSubcutaneous | 59137-550 | 59137-0550-0159137-0550-04 | — |
Medexus Pharma Inc.: common questions
- What is Medexus Pharma Inc.'s NDC labeler code?
- 59137. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Medexus Pharma Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.